Random Musings From The Clinical Trials Guru Clinical Research Study Startup Workflow Ep. 1045
Mar 24, 2026
A deep dive into why research sites and coordinators slow study startup and which tasks resist automation. Coverage of parallel startup workflows like contracts, IRB submissions, budgets and regulatory paperwork. Discussion of signature bottlenecks, credential-sharing tools, vendor portal overload and the logistics of receiving investigational product. Notes on SIVs, pre-screening readiness and EDC automation efforts.
AI Snips
Chapters
Books
Transcript
Episode notes
Sites Are The Real Industry Bottleneck
- Sites are the industry bottleneck where physical world constraints meet technological innovation.
- Dan Sfera explains sites hold the profits now and can't simply be fixed by throwing money or tech at them because patient interaction remains physical.
Study Startup Tasks Are Highly Automatable
- Many study startup tasks are highly repetitive and ripe for AI automation, especially IRB and essential document assembly.
- Dan notes templates, repeated questions, and signature collection are predictable workflows that AI agents can handle.
Signatures Remain A Human Bottleneck
- The human signature step remains a stubborn bottleneck because investigators ignore emails and lack time.
- Dan emphasizes that getting PIs to sign documents often requires persistent human follow-up, which technology alone doesn't fix.
